AstraZeneca PLC Operating Cycle 2011-2026 | AZN

Annual Operating Cycle AstraZeneca PLC

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	206	168	122	132	139	112

All numbers in USD currency

Maximum	Minimum	Average
206	112	147

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Axsome Therapeutics AXSM	273	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	285	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
BioCardia BCDA	101	$ 1.37	5.81 %	$ 29 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	733	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	153	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	141	$ 10.93	0.23 %	$ 450 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
BioXcel Therapeutics BTAI	244	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Catalyst Biosciences CBIO	410	$ 11.67	-3.47 %	$ 768 M	USA
C4 Therapeutics CCCC	27.9	$ 3.06	13.3 %	$ 254 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Codexis CDXS	50.2	$ 0.99	-2.04 %	$ 72.7 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA